Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin. (14th May 2020)

• Record Type: Journal Article
• Authors: Dessinioti, C.; Zouboulis, C.C.; Bettoli, V.; Rigopoulos, D.
• Is Part Of: Journal of the European Academy of Dermatology and Venereology. Volume 34:Number 10(2020)
• Page Start: 2229
• Page End: 2240
• Publication Date: 2020-05-14
• Subjects: Dermatology -- Periodicals; Sexually transmitted diseases -- Periodicals; 616.5
• DOI: 10.1111/jdv.16430
• Languages: English
• ISSNs: 0926-9959

Abstract

Abstract: Guidelines and consensus on the management of patients with acne aim to give evidence‐based, expert‐group recommendations. This review compares current guidelines and consensus articles to provide a compilation of recommendations on the treatment of acne with oral isotretinoin. Ten common, relevant, clinical questions are addressed, based on published recommendations, including the indications of isotretinoin, the proposed daily dose, the cumulative isotretinoin dose and the laboratory monitoring needed. Recommendations on special considerations are also addressed, including the timing of procedures and the question of an association of depression or inflammatory bowel disease with isotretinoin. A major limitation is the use of different classification systems for acne across guidelines. The recommended daily dose ranges from 0.3 to 0.5 mg/kg in the European guidelines to up to 1 mg/kg in the US guidelines. A specific duration of treatment of at least 6 months is only recommended in the European guidelines. All guidelines report the need of strict pregnancy prevention measures. The European, French and US guidelines recommend to monitor for symptoms of depression. Important clinical questions that are inconsistently addressed in guidelines include the age indication, the recommendation for a cumulative dose, the timing of procedures, the association of isotretinoin with IBD, the recommendation for preventing acne flares and for appropriate laboratory monitoring. These topics should be clearly included in the recommendations of guidelines as they are often raised in everyday clinical practice.